Desensitization Protocol Administered Successfully with interferon-?; 2a in a child with chronic hepatitis b infection

Basit Öğe Kaydı
dc.contributor.authorKilic, M.
dc.contributor.authorDogan, Y.
dc.contributor.authorTaskin, E.
dc.contributor.authorSen, Y.
dc.contributor.authorKalpaklioglu, A.F.
dc.date.accessioned2026-08-12T16:13:52Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage448
dc.identifier.issn1698-0808
dc.identifier.issue5
dc.identifier.pmid20945616
dc.identifier.scopus2-s2.0-78649423344
dc.identifier.scopusqualityQ2
dc.identifier.startpage447
dc.identifier.urihttps://hdl.handle.net/11508/43268
dc.identifier.volume20
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.relation.ispartofJournal of Investigational Allergology and Clinical Immunology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectAngioedema; Child, Preschool; Clinical Protocols; Desensitization, Immunologic; Drug Hypersensitivity; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon Alfa-2a; Interferon Alfa-2b; Male; Urticaria; alpha2a interferon; alpha2b interferon; antihistaminic agent; angioneurotic edema; article; case report; child; chronic hepatitis; clinical effectiveness; clinical protocol; desensitization; disease duration; disease severity; dose response; drug hypersensitivity; drug withdrawal; follow up; hepatitis B; human; male; preschool child; single drug dose; skin test; treatment duration; treatment outcome; urticaria
dc.titleDesensitization Protocol Administered Successfully with interferon-?; 2a in a child with chronic hepatitis b infection
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu